Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Seattle Genetics Inc (SGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,860,642
  • Shares Outstanding, K 160,561
  • Annual Sales, $ 654,700 K
  • Annual Income, $ -222,690 K
  • 60-Month Beta 2.32
  • Price/Sales 18.15
  • Price/Cash Flow N/A
  • Price/Book 9.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.28
  • Number of Estimates 7
  • High Estimate 0.00
  • Low Estimate -0.40
  • Prior Year -0.61
  • Growth Rate Est. (year over year) +54.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.81 +11.03%
on 03/07/19
76.08 -1.04%
on 03/26/19
+3.86 (+5.40%)
since 02/26/19
3-Month
54.03 +39.35%
on 12/27/18
78.06 -3.55%
on 02/01/19
+18.49 (+32.55%)
since 12/26/18
52-Week
47.75 +57.68%
on 04/25/18
84.37 -10.76%
on 10/03/18
+21.72 (+40.55%)
since 03/26/18

Most Recent Stories

More News
Look for Shares of Seattle Genetics to Potentially Pullback after Yesterday's 1.96% Rise

Seattle Genetics (NASDAQ:SGEN) traded in a range yesterday that spanned from a low of $75.29 to a high of $75.57. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high...

SGEN : 75.29 (+1.92%)
SmarTrend Watching for Potential Pullback in Shares of Seattle Genetics After 1.41% Gain

Seattle Genetics (NASDAQ:SGEN) traded in a range yesterday that spanned from a low of $74.26 to a high of $75.43. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high...

SGEN : 75.29 (+1.92%)
Seattle Genetics (SGEN) Down 6.1% Since Last Earnings Report: Can It Rebound?

Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SGEN : 75.29 (+1.92%)
Look for Shares of Seattle Genetics to Potentially Rebound after Yesterday's 2.45% Sell Off

Seattle Genetics (NASDAQ:SGEN) traded in a range yesterday that spanned from a low of $70.11 to a high of $71.21. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of...

SGEN : 75.29 (+1.92%)
Seattle Genetics to Present at Cowen and Company 39th Annual Health Care Conference

Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at the Cowen and Company 39th Annual Health Care Conference on Tuesday, March 12, 2019 at 10:40 a.m. Eastern...

SGEN : 75.29 (+1.92%)
Biotechnology Companies see Rising Demand for new Therapies

The biotechnology market is one of the biggest industries in the world. However, despite being the largest sector globally, there are still various segments that haven't been tapped into, presenting opportunities...

QGEN : 40.41 (+1.61%)
SGEN : 75.29 (+1.92%)
PBIO : 3.2000 (+6.67%)
GE : 10.10 (+2.23%)
NKTR : 32.32 (-0.15%)
Look for Shares of Seattle Genetics to Potentially Rebound after Yesterday's 1.38% Sell Off

Seattle Genetics (NASDAQ:SGEN) traded in a range yesterday that spanned from a low of $68.37 to a high of $69.70. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of...

SGEN : 75.29 (+1.92%)
Biotech Stock Roundup: Regeneron Impresses in Q4, Gilead Slumps, MacroGenics Soars

Key highlights of the week were fourth-quarter results from Regeneron Pharmaceuticals and Ligand Pharmaceuticals along with other regulatory and pipeline updates.

MGNX : 19.94 (+1.63%)
LGND : 123.14 (+0.01%)
INCY : 87.12 (+1.28%)
GILD : 64.24 (+0.71%)
SGEN : 75.29 (+1.92%)
REGN : 405.62 (+2.69%)
New Research: Key Drivers of Growth for Phillips 66, Seattle Genetics, Green Plains, C&J Energy Services, FRP, and Medical Transcription Billing -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Phillips 66 (NYSE:PSX), Seattle...

PSX : 98.02 (+2.25%)
FRPH : 47.89 (+0.42%)
CJ : 15.59 (+2.50%)
SGEN : 75.29 (+1.92%)
MTBC : 4.55 (-0.44%)
GPRE : 16.83 (-0.65%)
Seattle Genetics' Adcetris Gets EC Nod for Label Expansion

Seattle Genetics' (SGEN) partner, Takeda Pharmaceutical receives EC approval for Adcetris in combination with AVD to treat adults with previously untreated CD30+ stage IV cHL.

NVO : 51.94 (+0.74%)
MRK : 82.92 (+0.69%)
SGEN : 75.29 (+1.92%)
BMY : 48.34 (+1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade SGEN with:

Business Summary

Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability...

See More

Key Turning Points

2nd Resistance Point 77.52
1st Resistance Point 76.40
Last Price 75.29
1st Support Level 73.85
2nd Support Level 72.42

See More

52-Week High 84.37
Last Price 75.29
Fibonacci 61.8% 70.38
Fibonacci 50% 66.06
Fibonacci 38.2% 61.74
52-Week Low 47.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar